Valsoft Enters the Life Sciences Space with the Acquisition of Anju Software
Summary
Anju is a customer-focused organization providing adaptable solutions that offer clients an excellent experience in simplifying the intricacies of life science information management. The companys flagship products, TrialMaster, IRMS MAX, and TA Scan, reduce complexities in the drug and device discovery and commercialization process allowing customers to enhance the quality of their patients lives. "The consistent global growth and customer satisfaction at Anju are a clear reflection of the teams hard work and commitment over the years," says Sam Youssef, CEO of Valsoft. Their technologies facilitate data flow between Anju software solutions and seamless communication with third-party systems, providing a unique opportunity for their customers to leverage critical information and drive impactful results. Unlike private equity and VC firms, Valsoft does not have a predefined investment horizon and looks to buy, hold, and create value through long-term partnerships with existing management and customers.